CAPRICOR THERAPEUTICS, INC. IR

press release

PDF: Capricor Therapeutics Reports Third Quarter 2017 Financial Results and Provides Update on Duchenne Muscular Dystrophy Development Program

Source document

Issuer site

Loading document…

PDF: Capricor Therapeutics Reports Third Quarter 2017 Financial Results and Provides Update on Duchenne Muscular Dystrophy Development Program — CAPRICOR THERAPEUTICS, INC.